Pharmaceutical composition with ascites eliminating effect

A composition and medicine technology, applied in the field of traditional Chinese medicine compositions, can solve problems such as difficulty in obtaining a satisfactory curative effect, and achieve the effects of being conducive to gaining time, reducing the recurrence rate and having obvious effects.

Inactive Publication Date: 2016-05-18
何立荣
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] Existing drugs are difficult to obtain satisfactory curative effect on abdominal hydrops, especially ascites and severe ascites accompanied by liver disease

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0025] The preparation of embodiment one pharmaceutical composition of the present invention

[0026] Take 300g of astragalus, 100g of Hovenia dulcis, 200g of betel nut, 200g of turtle shell, 30g of Ziheche, 50g of red ginseng, 120g of Shijianchuan, 100g of curcuma, 100g of Alisma, 150g of Shuihonghuazi, 150g of white poria, August Zha 100g, turmeric 100g, pulverize, sieve, add auxiliary materials according to the ratio of drug total mass: auxiliary material total mass=1: 0.4, auxiliary materials are starch and sucrose (in terms of mass ratio, starch: sucrose=1: 1), made tablet.

Embodiment 2

[0027] The preparation of embodiment two pharmaceutical compositions of the present invention

[0028]Take 150g of Astragalus membranaceus, 100g of Hovenia dulcis, 200g of betel nut, 200g of turtle shell, 20g of Ziheche, 30g of red ginseng, 100g of Shijianchuan, 100g of curcuma, 100g of Alisma, 100g of Shuihonghuazi, 120g of white poria, August Zha 100g, turmeric 80g, were decocted in water for 2 hours, filtered, got decoction, dried, and obtained extractum; add auxiliary materials according to the ratio of total drug mass: total mass of auxiliary materials=1: 0.01, auxiliary materials are microcrystalline cellulose and sucrose (with In terms of mass ratio, microcrystalline cellulose: sucrose = 1:1), pass through a 100-mesh sieve, granulate, dry, pack into medicinal capsules, and obtain capsules.

Embodiment 3

[0029] The preparation of embodiment three pharmaceutical compositions of the present invention

[0030] Take 500g of Astragalus membranaceus, 180g of Hovenia dulcis, 240g of betel nut, 350g of turtle shell, 90g of Ziheche, 100g of red ginseng, 150g of Shijianchuan, 100g of curcuma, 180g of Alisma, 150g of Shuihonghuazi, 150g of white poria, August 150g of zucchini, 120g of turmeric, decoct in water for 1 hour, filter, take decoction, dry to obtain extract; according to the ratio of the total mass of medicine fed: the total mass of auxiliary materials = 1: 0.02, the extract is mixed with auxiliary materials, and the auxiliary materials are microcrystalline Cellulose, starch and sucrose (in terms of mass ratio, microcrystalline cellulose:starch:sucrose=1:1:1) are granulated through a 50-mesh sieve, and dried to obtain granules.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a pharmaceutical composition for treating liver ascites. The curative effect of the pharmaceutical composition on the ascites caused by hepatitis and cirrhosis is exact, the ascites subsides quickly and safely and the long-term effect is relatively good. The invention also provides a combined drug which has a remarkable treatment effect on liver ascites.

Description

technical field [0001] The invention belongs to the field of traditional Chinese medicine, and in particular relates to a traditional Chinese medicine composition and its application. Background technique [0002] Liver cirrhosis is a common disease worldwide, ranking 4th or 6th among the causes of human death. It is regarded as the main "killer" of human health and poses a serious threat to human health and social development. Liver cirrhosis caused by viral hepatitis accounts for about 68% of liver cirrhosis in my country. The annual incidence of liver cirrhosis in patients with chronic hepatitis B is 2% to 10%, the annual incidence of liver function decompensation from compensated liver cirrhosis is 3% to 5%, and the 5-year survival rate of decompensated liver cirrhosis The rate is 14% to 35%. The annual incidence of HCC in patients with liver cirrhosis is 3% to 6%. In order to more accurately predict the disease progression and determine the risk of death in patients ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/9066A61P1/16A61P7/10A61K35/50A61K35/586A61K31/704A61K31/138
CPCA61K36/481A61K9/1652A61K9/2059A61K9/4866A61K31/138A61K31/704A61K35/50A61K35/586A61K36/076A61K36/185A61K36/258A61K36/53A61K36/70A61K36/72A61K36/884A61K36/9066A61K2300/00
Inventor 何立荣何刚李兵杨敏肖成东
Owner 何立荣
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap